Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation

S. Dietrich, P. Dreger, O. Hermine, C. Kyriakou, S. Montoto, S. Robinson, N. Schmitz, H.C. Schouten, A. Sureda, A. Tanase

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)317-324
Number of pages8
JournalBone Marrow Transplantation
Volume55
Issue number2
DOIs
Publication statusPublished - 1 Feb 2020

Keywords

  • cd3/cd19 depletion
  • hematologic malignancies
  • high-risk
  • non-hodgkin-lymphoma
  • outcomes
  • posttransplantation cyclophosphamide
  • reduced-intensity
  • sct
  • therapy
  • unrelated donor transplantation
  • SCT
  • UNRELATED DONOR TRANSPLANTATION
  • CD3/CD19 DEPLETION
  • REDUCED-INTENSITY
  • THERAPY
  • HIGH-RISK
  • POSTTRANSPLANTATION CYCLOPHOSPHAMIDE
  • NON-HODGKIN-LYMPHOMA
  • OUTCOMES
  • HEMATOLOGIC MALIGNANCIES

Cite this